Here are all our ongoing and concluded projects:
ONGOING PROJECTS
RESYNC: EIC Pathfinder to unravel a novel therapeutic approach against cancer based on cell reprogramming
START: 1ST Jan 2024, Duration: 36 months. ONGOING
EIC PATHFINDER OPEN from Horizon Europe
Title: Functional chemical reprogramming of cancer cells to induce antitumor immunity
NANOZOOM: PoC NODES grant to explore the nanoimaging capabilities of nanoparticles under ultrasound-based diagnostics
Start 13th December 2023, Duration 14 months, ONGOING
Health Industry and Silver Economy – Ministry of University and Research and Recovery Plan in Italy (PNNR). Title: Nanoparticles as innovative high-contrast agents resolution and depth for tumor imaging
HyNPs: PoC EIC Linea 3 from LifTT funding
Follow on project related to XtraUS ERC PoC.
Start: 18th Sep 2023 , Duration: 12 months. ONGOING
PoC EIC Linea 3 from LifTT funding, title: Anti-tumor therapy based on ultrasound activation and synergy with biocompatible nanoparticles
MIMIC-KeY: FET Open grant to design artificial EV mimics to treat lysosomal bone metabolic disease.
Start 1/6/2021, duration 48 months. ONGOING
H2020-FET-OPEN-RIA-2020 call with GA N. 964386, title: A KEY to the Understanding of Extracellular Vesicles and Rational Design of MIMICKING Nanoparticles
CRRT: Proof of concept for effective dose monitoring in dialysis
Start 16/05/2022, duration 9 months. ONGOING
LIFTT PoC Instrument, title: Current effective delivered dose monitoring for continuous renal replacement therapy
MITHoS: National research grant for theranostic nanosystems against multiple myeloma
Start 22/3/2022, duration 36 months. ONGOING
PRIN 2020, title: Multimodal Innovative THeranostic nanoSystem
CONCLUDED PROJECTS
AI CUrES: ERC Proof of Concept grant to predict cancer metastasis
Start 1/11/2022, duration 18 months. CONCLUDED
ERC-2022-PoC call with GA 101081529, title: AI to predict Cancer metastasis using Ultra-Echo-Sono imaging
XtraUs: ERC Proof of Concept grant to prevent cancer recurrence
Start 1/3/2021, duration 20 months. CONCLUDED
ERC-2020-PoC call with GA 957563, title: “Fighting cancer relapse with remote activation of smart and targeted nanoconstructs”
TrojaNanoHorse: ERC starting grant to fight cancer with theranostic nanosystems.
Start 1/3/2016, duration 66 months. CONCLUDED
ERC StG 2015 call with GA 678151, title: ““Hybrid immune-eluding nanocrystals as smart and active theranostic weapons against cancer”
MINT: Marie Curie Individual fellowship on multifunctional nanotheranostics against pancreatic cancer
Start 1/9/2019, duration 24 months. CONCLUDED
MSCA-IF with GA n. 842964, title: Multifunctional Immunocompatible NanoTheranostics to modulate tumor microenvironment and improve treatment monitoring: A double blow to pancreatic cancer
Nanopils: Proof of Concept for targeted drug delivery by means of nanoporous biomimetic vehicles
Start 1/7/2020, duration 12 months. CONCLUDED
LIFTT PoC Instrument, title: Vettore nanoporoso biomimetico per massimizzare l’efficacia terapeutica degli inibitori del proteasoma
U-Care: MEDICAL DEVICE for Urine Output MONITORING for prediction of Acute Kidney Injury. CONCLUDED
LIFTT Proof of concept – VV3TT 2018 POC Program
